News for AXIM Biotechnologies, Inc. (AXIM)

Leading Diagnostic Healthcare Company Also Announces Over 50 Initial Clinic Commitments for Its Full Diagnostic Assay Platform SAN DIEGO, CA, July...

Leading Diagnostic Healthcare Company Also Announces Over 50 Initial Clinic Commitments for Its Full Diagnostic Assay Platform SAN DIEGO, CA, July 12,...

Leading Dry Eye Disease Diagnostic Healthcare Company’s Assays to be Performed in Over 40 Initial Clinics Across US SAN DIEGO, CA, May 24, 2023 ...

Diagnostic Healthcare Solutions Company Developing New Test Designed to Measure Neutralizing Antibodies of Deadly Opioid Fentanyl SAN DIEGO, CA, Jan. 17,...

Leading Diagnostic Healthcare Company Announces Development of and Provisional Patent Filing on First-of-Its-Kind Point-of-Care Ophthalmological Diagnostic Solution Enabling Precision Treatment of... | December 13, 2022

Healthcare Solutions Company Receives Initial Order for Ophthalmic Diagnostic Tests and Readers, Marking First Large Revenue Generating Order for CompanySAN DIEGO, Oct. 04, 2022 -- AXIM... | October 4, 2022

Sales of Point-of-Care Diagnostic Tests for Ocular Surface Disease Commence at the American Academy of Ophthalmology Annual Meeting Through Exclusive...

Ownership Submission FORM 4 Check this box if no longer... | September 23, 2022

Under the Agreement the Company will Sell and Distribute Globally AXIM’s Readers and Three Novel Proprietary Tests Designed for Diagnosis of Dry Eye DiseaseSAN DIEGO, Sept. 19, 2022 -- AXIM... | September 19, 2022

Read AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Short Interest Down 19.9% in August at ETF Daily News